Search Results 1431-1440 of 16566 for alt

1. A Study To Evaluate The Impact On Metastases-free Survival With The Addition Of Saruparib Versus Placebo To A Standard Radiotherapy/androgen Deprivation Regimen In Men With High-risk Prostate Cancer With A BRCA Mutation. - Mayo Clinic

   ALT and AST ≤ 2.5 × ULN (see Appendix E 6 and Appendix E 4.2). eGFR of ≥ 45 mL/min/1.73 m2 as determined by CKD-EPI formula (Inker et al 2021):. For ...

2. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

   ... [ALT]) ≤ 2.5 x institutional ULN; Direct bilirubin ≤ 1.5 mg/dL; Serum creatinine ≤ 2.5 mg/dL; Patients must be tested for hepatitis B surface antigen (HBsAg) ...

3. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia - Mayo Clinic

   Serum glutamic pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) ≤ 5.0 x ULN for age (≤ 225 U/L); for the purpose of this study, the ULN for SGPT ...

4. A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy (X-TOLE) - Mayo Clinic

   Alanine transferase (ALT; SGPT) or aspartate transferase (AST; SGOT) levels >3 times the upper limit of normal (ULN) at screening or baseline. Any ...

5. A Study to Evaluate AL102 to Treat Patients with Progressing Desmoid Tumors - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) \>2.5x ULN, 6. Serum creatinine \> ULN and creatinine clearance (CrCl) \<60 mL/min ...

6. A Study of ABC294640 (Yeliva®) in the Treatment of Patients with Advanced Cholangiocarcinoma - Mayo Clinic

   AST (SGOT), ALT (SGPT) ≤ 2.5 x upper limit of normal (ULN);; Serum creatinine ≤ 1.5 X ULN (NCI-CTCAE Grade 1 baseline);; Albumin > 3.0 g/dL. Acceptable ...

7. Decitabine Dose-Tolerance in Surgically Resectable HPV-Negative Head and Neck Cancer - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤3 x ULN (≤5 x ULN for patients with liver involvement); PT/INR/aPTT ≤1.5 x ULN OR if ...

8. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy - Mayo Clinic

   AST or ALT 2.5 > the upper limit of normal (ULN);; Amylase or lipase > 2 x ULN;; Neutrophils < 1.5 x 10^3 /µL;; CD19+ B cells < 5/µL;; Positive for hepatitis B ...

9. Hepatocellular carcinoma (HCC) - Symptoms and causes - Mayo Clinic

   Related. Associated Procedures. Alanine aminotransferase (ALT) blood test · Alkaline phosphatase (ALP) blood test · Aspartate aminotransferase (AST) blood test ...

10. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial - Mayo Clinic

    [SGOT])/alanine aminotransferase (ALT)(serum glutamic pyruvic transaminase [SGPT]) =< 3.0 x institutional upper limit of normal (ULN) (obtained =< 14 days ...